We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RPC:NYSERidgepost Capital, Inc. Analysis

Data as of 2026-04-29 - not real-time

$7.92

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock trades well below its 20‑day and 50‑day moving averages, indicating a bearish price momentum. The MACD histogram is positive, suggesting a modest bullish momentum beneath the broader downtrend. Relative strength index sits in the upper mid‑range, showing limited upside pressure. Valuation multiples are markedly higher than the sector average, pointing to an overvalued condition. The company’s price‑to‑book and price‑to‑sales ratios also exceed typical peer levels. Liquidity has been weakening, with daily volume trending lower than its recent averages.
Fundamentally, revenue is contracting and profit margins are thin, while debt levels are high relative to equity, raising concerns about financial resilience. Cash generation from operations is modest and the dividend payout ratio is near the upper limit, questioning dividend sustainability. A recent Zacks upgrade to a strong‑buy reflects optimism around earnings improvement. However, the DCF model suggests a fair value far below the current market price, reinforcing the overvaluation view. Given the high beta and pronounced price swings, the stock is exposed to significant market risk. Investors may consider positioning for a potential correction while monitoring the company’s ability to improve cash flow and reduce leverage.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • bearish technical indicators
  • price near resistance with limited upside
  • high volatility and beta

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • recent earnings upgrade signaling potential improvement
  • concerns about dividend sustainability
  • elevated debt load

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • long‑term growth of private market assets
  • diversified multi‑asset platform
  • potential for valuation re‑rating as cash flow strengthens

Key Metrics & Analysis

Financial Health

Revenue Growth-4.70%
Profit Margin6.56%
P/E Ratio46.6
ROE5.81%
ROA6.24%
Debt/Equity99.86
P/B Ratio2.5
Op. Cash Flow$23.0M
Free Cash Flow$37.5M
Industry P/E17.5

Technical Analysis

TrendBearish
RSI58.1
Support$6.79
Resistance$8.08
MA 20$7.48
MA 50$7.66
MA 200$10.10
MACDBullish
VolumeDecreasing
Fear & Greed Index89.59

Valuation

Fair Value$1.29
Target Price$15.25
Upside/Downside92.55%
GradeOvervalued
TypeValue
Dividend Yield1.89%

Risk Assessment

Beta1.59
Volatility42.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.